Global pharma, health and wellness company spanning CDMO, complex hospital generics, and OTC consumer healthcare.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 995 | 1.2k | 1.2k | 1.3k | 1.3k | 1.3k | 1.3k |
| Reserves | 4.6k | 5.5k | 5.6k | 6.6k | 6.8k | 6.7k | 6.8k |
| Borrowings | 3.0k | 4.1k | 5.6k | 4.7k | 4.9k | 4.9k | 5.7k |
| Other Liabilities | 2.0k | 1.8k | 1.9k | 2.5k | 2.4k | 3.3k | 3.8k |
| Total Liabilities | 10.7k | 12.6k | 14.3k | 15.1k | 15.4k | 16.2k | 17.6k |
| AssetsFixed Assets | 6.1k | 6.9k | 7.5k | 8.0k | 8.1k | 8.8k | 8.7k |
| CWIP | 627 | 1.2k | 1.4k | 1.1k | 977 | 567 | 1.1k |
| Investments | 123 | 267 | 639 | 385 | 291 | 442 | 437 |
| Other Assets | 3.8k | 4.3k | 4.8k | 5.6k | 6.0k | 6.4k | 7.4k |
| Total Assets | 10.7k | 12.6k | 14.3k | 15.1k | 15.4k | 16.2k | 17.6k |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
PPLPHARMA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.